AstraZeneca Heart Drugs Demand Increases After Trial Results

January 14, 2015 11:01 AM

16 0

AstraZeneca announced that BRILINTA showed promising results in reducing the risk of heart attacks in patients.

Brilinta is an anti clotting drug that doctors usually prescribe after a year of heart attack. Plavix, which is the generic name of the drug, significantly lessen the heart issues of the patients. The drug is relatively more effective as compared to aspirin.

Read more

To category page